BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23918341)

  • 1. Polyaspartic acid coated iron oxide nanoprobes for PET/MRI imaging.
    Cowger T; Xie J
    Methods Mol Biol; 2013; 1025():225-35. PubMed ID: 23918341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
    Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
    J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin α
    Shi X; Shen L
    J Inorg Biochem; 2018 Sep; 186():257-263. PubMed ID: 29990749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents.
    Bouziotis P; Psimadas D; Tsotakos T; Stamopoulos D; Tsoukalas C
    Curr Top Med Chem; 2012; 12(23):2694-702. PubMed ID: 23339765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle.
    Kim SM; Chae MK; Yim MS; Jeong IH; Cho J; Lee C; Ryu EK
    Biomaterials; 2013 Nov; 34(33):8114-21. PubMed ID: 23932293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality PET/MRI agents targeted to activated macrophages.
    Tu C; Ng TS; Jacobs RE; Louie AY
    J Biol Inorg Chem; 2014 Feb; 19(2):247-58. PubMed ID: 24166283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled ultra-small Fe
    Sun H; Zhang B; Jiang X; Liu H; Deng S; Li Z; Shi H
    Nanomedicine (Lond); 2019 Jan; 14(1):5-17. PubMed ID: 30451578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.
    Yang X; Hong H; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Xiao Y; Yang Y; Zhang Y; Nickles RJ; Cai W; Steeber DA; Gong S
    Biomaterials; 2011 Jun; 32(17):4151-60. PubMed ID: 21367450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
    Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
    J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles.
    Su T; Wang YB; Han D; Wang J; Qi S; Gao L; Shao YH; Qiao HY; Chen JW; Liang SH; Nie YZ; Li JY; Cao F
    Theranostics; 2017; 7(19):4791-4804. PubMed ID: 29187904
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbon-coated FeCo nanoparticles as sensitive magnetic-particle-imaging tracers with photothermal and magnetothermal properties.
    Song G; Kenney M; Chen YS; Zheng X; Deng Y; Chen Z; Wang SX; Gambhir SS; Dai H; Rao J
    Nat Biomed Eng; 2020 Mar; 4(3):325-334. PubMed ID: 32015409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel peptide targeting integrin αvβ3-rich tumor cells by magnetic resonance imaging.
    Wu G; Wang X; Deng G; Wu L; Ju S; Teng G; Yao Y; Wang X; Liu N
    J Magn Reson Imaging; 2011 Aug; 34(2):395-402. PubMed ID: 21780231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents.
    Patel D; Kell A; Simard B; Xiang B; Lin HY; Tian G
    Biomaterials; 2011 Feb; 32(4):1167-76. PubMed ID: 21035183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/NIRF/MRI triple functional iron oxide nanoparticles.
    Xie J; Chen K; Huang J; Lee S; Wang J; Gao J; Li X; Chen X
    Biomaterials; 2010 Apr; 31(11):3016-22. PubMed ID: 20092887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality probes: amphibian cars for molecular imaging.
    Boerman OC; Oyen WJ
    J Nucl Med; 2008 Aug; 49(8):1213-4. PubMed ID: 18632805
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free
    Madru R; Budassi M; Benveniste H; Lee H; Smith SD; Schlyer DJ; Vaska P; Knutsson L; Strand SE
    Cancer Biother Radiopharm; 2018 Aug; 33(6):213-220. PubMed ID: 30036073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle.
    Hurley KR; Ring HL; Etheridge M; Zhang J; Gao Z; Shao Q; Klein ND; Szlag VM; Chung C; Reineke TM; Garwood M; Bischof JC; Haynes CL
    Mol Pharm; 2016 Jul; 13(7):2172-83. PubMed ID: 26991550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-conjugated iron oxide magnetic nanoparticles for magnetic resonance imaging contrast enhancement and hyperthermia.
    Zheng SW; Huang M; Hong RY; Deng SM; Cheng LF; Gao B; Badami D
    J Biomater Appl; 2014 Mar; 28(7):1051-9. PubMed ID: 23796630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10-NGR9 ultrasmall superparamagnetic iron oxide nanoparticles.
    Wu T; Ding X; Su B; Soodeen-Lalloo AK; Zhang L; Shi JY
    Clin Transl Oncol; 2018 May; 20(5):599-606. PubMed ID: 28956266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging.
    Torres Martin de Rosales R; Tavaré R; Glaria A; Varma G; Protti A; Blower PJ
    Bioconjug Chem; 2011 Mar; 22(3):455-65. PubMed ID: 21338098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.